- Report
- February 2025
- 120 Pages
Global
From €2217EUR$2,490USD£1,928GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- August 2025
- 185 Pages
Global
From €3156EUR$3,545USD£2,745GBP
€3507EUR$3,939USD£3,051GBP
- Report
- June 2025
- 400 Pages
Global
From €4406EUR$4,949USD£3,833GBP
- Report
- October 2024
- 202 Pages
Global
From €2181EUR$2,450USD£1,897GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- August 2025
- 192 Pages
Global
From €3156EUR$3,545USD£2,745GBP
€3507EUR$3,939USD£3,051GBP
- Report
- September 2025
- 182 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- August 2025
- 225 Pages
Global
From €2226EUR$2,500USD£1,936GBP
- Report
- June 2025
- 400 Pages
Global
From €4406EUR$4,949USD£3,833GBP
- Report
- May 2025
- 206 Pages
Global
From €4447EUR$4,995USD£3,868GBP
- Report
- April 2025
- 170 Pages
Global
From €4447EUR$4,995USD£3,868GBP
- Report
- August 2025
- 149 Pages
Global
From €2670EUR$2,999USD£2,323GBP
- Report
- June 2025
- 200 Pages
Japan
From €2217EUR$2,490USD£1,928GBP
- Book
- March 2021
- 400 Pages
From €147EUR$165USD£128GBP
- Report
- August 2025
- 150 Pages
Global
From €2670EUR$2,999USD£2,323GBP
- Report
- August 2022
- 115 Pages
Global
From €4229EUR$4,750USD£3,679GBP
- Report
- January 2024
- 200 Pages
Global
From €3694EUR$4,150USD£3,214GBP

Inflammatory Bowel Disease (IBD) is a group of chronic disorders that cause inflammation of the gastrointestinal tract. It is a major area of focus within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of IBD. Symptoms of IBD can include abdominal pain, diarrhea, rectal bleeding, and weight loss. Treatment options include medications, lifestyle changes, and surgery.
IBD is a growing area of research and development, with many companies developing new treatments and therapies. Companies such as AbbVie, Janssen, and Takeda are researching and developing new drugs to treat IBD. Other companies such as Enterome, Immuron, and Seres Therapeutics are developing microbiome-based therapies to treat IBD. Additionally, companies such as Medtronic and Boston Scientific are developing medical devices to treat IBD. Show Less Read more